<< Read Full Article
<< Read Full Article
It's been a good week for health-care funds.
This past week, Johnson & Johnson's (JNJ Quote) first-ever AIDS treatment, Prezista, won entry for sale to the 27 European Union countries.
Merck (MRK Quote) announced the distribution of its AIDS drug Atripla to certain poor countries at cost, and Thailand, declaring an emergency, is breaking Bristol-Myers Squibb's (BMY Quote) patent on the HIV drug Sustiva to create a generic version. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,309.92 | 1,091.49 | 2,138.44 | 32.42 |
Oil *
77.14
|
|
DOWN
154.48
|
DOWN
19.14
|
DOWN
37.61
|
UP
0.11
|
10 Yr
3.24%
SPDR Gold
115.06
|
|
-1.48%
|
-1.72%
|
-1.73%
|
+0.34%
|
Data delayed 20 minutes |


Connect with TheStreet